Two patients with amiodarone-induced thyrotoxicosis were treated successfilly with potassium perchlorate and carbimazole while treatment with amiodarone was continued. These antithyroid drugs were stopped after the patients had became clinically and biochemically euthyroid. During follow up, when treatment with amiodarone continued, thyrotoxicosis did not recur.
Amiodarone is an effective antiarrhythmic agent with a high iodine content that affects the production and secretion of thyroid hormones and in some patients induces overt thyrotoxicosis or hypothyroidism. The mechanism responsible is incompletely understood. An iodine excess is not the prime determinant.' Amiodarone could induce hypothyroidism by unmasking a pre-existing subclinical abnormality.
Amiodarone induced thyrotoxicosis is unpredictable with an unexplained sudden onset in patients with previously normal thyroid function and without pre-existing thyroid antibodies. The chief hypothesis for the pathogenesis of amiodarone induced thyrotoxicosis is that amiodarone or its metabolites damage the thyroid cells and disrupt follicles, Department of Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued After 37 months, when the cumulative amiodarone dose was 44 g, overt amiodarone induced thyrotoxicosis developed. Serum T4 and FT4 concentrations were extremely high. One week later thyroxine and triiodothyronine concentrations had already fallen slightly. Treatment with carbimazole (40 mg/day) and potassium perchlorate (1 g/day) was started, while amiodarone medication was continued. The patient became clinically euthyroid after two months. When the thyroid stimulating hormone concentration became normal six months later, the anti-thyroid medication was stopped. Though he continued to take amiodarone, confirmed by measuring the serum concentrations of amiodarone and desethylamiodarone, thyroid dysfunction did not recur during the follow up of seven months. The patient died suddenly at home.
Discussion
Amiodarone induced thyrotoxicosis in these two patients was transient. It was successfully treated with a short course of antithyroid drugs while amiodarone was continued. When amiodarone is stopped because of amiodarone induced thyrotoxicosis life threatening tachycardia can recur. Under these circumstances total thyroidectomy has been advocated to allow treatment with amiodarone to continue.5 It is remarkable that a short course of antithyroid drugs restored euthyroidism, and that the patients remained euthyroid despite continuing treatment with amiodarone.
The mechanism of effects of amiodarone on the thyroid is multifactorial and largely Trip, Duren, Wiersinga unknown. Although auto-immune related thyrotoxicosis has been reported after amiodarone treatment,6 neither of our patients had a goiter or thyroid antibodies before amiodarone treatment and antibodies did not develop during follow up. These data suggest that amiodarone induced thyrotoxicosis has a peculiar pathogenesis. When intrathyroidal amiodarone concentrations exceed a threshold, cell damage leads to thyrotoxicosis when the contents of the thyroid leak into the bloodstream. The intra-thyroidal concentration of amiodarone too would decrease, allowing repair and the restoration of euthyroidism. If this hypothesis is true, continuation of amiodarone treatment might eventually lead to a recurrence of thyrotoxicosis when the intrathyroidal amoidarone concentration again exceeds the threshold.
In our patients the follow up period was probably too short for a second period of thyrotoxicosis to develop. 75. 
